After-Hours Stock Movers
C3.ai, Inc. (NYSE: AI) 27.4% HIGHER; has established a new five-year Production-Other Transaction Agreement with the U.S. Department of Defense (DoD).
American Outdoor Brands, Inc. (NASDAQ: AOUT) 17.9% LOWER; reported Q2 EPS of $0.58, $0.18 worse than the analyst estimate of $0.76. Revenue for the quarter came in at $70.8 million versus the consensus estimate of $82.55 million. American Outdoor Brands sees FY2022 EPS of $2.02-$2.21, versus the consensus of $2.27. American Outdoor Brands sees FY2022 revenue of $280-285 million, versus the consensus of $294.1 million.
Oracle (NYSE: ORCL) 9.7% HIGHER; reported Q2 EPS of $1.21, $0.10 better than the analyst estimate of $1.11. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $10.21 billion.
Chewy, Inc. (NYSE: CHWY) 7% LOWER; reported Q3 EPS of ($0.08), $0.04 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $2.21 billion versus the consensus estimate of $2.21 billion. Chewy sees Q4 2021 revenue of $2.4-2.44 billion, versus the consensus of $2.43 billion.
Broadcom (NASDAQ: AVGO) 6.7% HIGHER; reported Q4 EPS of $7.81, $0.40 better than the analyst estimate of $7.41. Revenue for the quarter came in at $7.6 billion, may not compare versus the consensus estimate of $7.36 billion. Broadcom sees Q1 2022 revenue of $7.6 billion, versus the consensus of $7.25 billion. First quarter Adjusted EBITDA guidance of approximately 61.5 percent of projected revenue.
R.R.Donnelley (NYSE: RRD) 3.9% HIGHER; Chatham Asset Management Increases Offer to $10.85 Per Share in Cash
Bottomline (NASDAQ: EPAY) 3% HIGHER; is exploring a sale, according to Bloomberg, citing people with knowledge of the matter.
Crown (NYSE: CCK) 2% HIGHER; announced today that its Board of Directors authorized the repurchase of an aggregate amount of up to $3.0 billion of Company stock through the end of 2024.
Lululemon Athletica (NASDAQ: LULU) 2% LOWER; reported Q3 EPS of $1.62, $0.21 better than the analyst estimate of $1.41. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.43 billion. lululemon athletica sees Q4 2021 EPS of $3.25-$3.32, versus the consensus of $3.30. lululemon athletica sees Q4 2021 revenue of $2.125-2.165 billion, versus the consensus of $2.17 billion.
Biocryst Pharmaceuticals (NASDAQ: BCRX) 1.5% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $16.00.
精彩评论